2025 - Bridging the Gap in Seronegative Rheumatoid Arthritis: Unlocking the Diagnostic and Prognostic Potential of RA33 Autoantibodies

Seronegative rheumatoid arthritis (SN RA) poses significant diagnostic and management challenges due to the lack of conventional biomarkers such as rheumatoid factor (RF) and anti-CCP antibodies, complicating timely and accurate diagnosis.
This webinar explores the emerging diagnostic and prognostic value of anti-RA33 autoantibodies (IgG, IgA and IgM) as novel biomarkers, capable of bridging the critical gap in SN RA clinical practice. Through a comprehensive review of existing diagnostic methods and their limitations, participants will understand why innovative biomarkers are urgently needed.
The expert speakers will delve into the historical discovery and usage of RA33 autoantibodies, integrating the latest research evidence demonstrating their effectiveness in clinical practice. Real-world clinical case examples will highlight how incorporating RA33 biomarkers enhances diagnostic accuracy, improves prognosis assessments and ultimately leads to better patient outcomes.
Join this webinar to discover how RA33 biomarkers are transforming clinical decision-making for patients with SN RA.
Keywords: Clinical Trials, Clinical Research, Arthritis, Osteoarthritis, Biomarkers, Rheumatoid Arthritis, Clinical Operations,  Biomarker Discovery, Diagnostics, Psoriatic Arthritis